: A Review of Antibiogram Journey in Developing Countries

Overview

Journal Infect Disord Drug Targets

Publisher Bentham Science Publishers

Specialty Infectious Diseases

Date 2024 Jan 24

PMID 38265374

Authors

Lipika Singhal

Diljot Sandhu

Varsha Gupta

Ivneet Kour

Affiliations

Soon will be listed here.

Abstract

Typhoid fever poses a significant health challenge in low- and middleincome countries (LMiCs), impacting millions of individuals across various age groups. Its prevalence is particularly pronounced in South Asia. Factors contributing to its transmission in South Asia include rapid unplanned urbanization, urban-rural disparities, provision of poor water and sanitation facilities, and open defecation. The mortality rate of typhoid fever is up to 1%, and those who survive have a protracted period of poor health and carry an enormous financial burden. The treatment is further complicated by the emerging antibiotic resistance leaving few treatment options in hands. This issue has become more urgent due to the further emergence of extended drug-resistant (XDR) and multidrug-resistant (MDR) typhoid strains, as well as their subsequent global spread. Fluoroquinolone-resistant spp. is currently classified by the World Health Organization (WHO) as a high (Priority 2) pathogen. As a result, establishing minimum inhibitory concentrations (MIC) according to the latest guidelines may prove effective in treating typhoid fever and minimizing the rising threat of drug resistance.

References

Singhal L, Gupta P, Kale P, Gautam V, Ray P . Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012). Indian J Med Microbiol. 2014; 32(2):149-52. DOI: 10.4103/0255-0857.129799. View

Antillon M, Warren J, Crawford F, Weinberger D, Kurum E, Pak G . The burden of typhoid fever in low- and middle-income countries: A meta-regression approach. PLoS Negl Trop Dis. 2017; 11(2):e0005376. PMC: 5344533. DOI: 10.1371/journal.pntd.0005376. View

Saad N, Lynch V, Antillon M, Yang C, Crump J, Pitzer V . Seasonal dynamics of typhoid and paratyphoid fever. Sci Rep. 2018; 8(1):6870. PMC: 5932015. DOI: 10.1038/s41598-018-25234-w. View

El-Sayed A, Kamel M . Climatic changes and their role in emergence and re-emergence of diseases. Environ Sci Pollut Res Int. 2020; 27(18):22336-22352. PMC: 7187803. DOI: 10.1007/s11356-020-08896-w. View

Agrawal S, Yadav V, Srivastava A, Kapil A, Dhawan B . Breast abscess due to A : Case reports with review of literature. Intractable Rare Dis Res. 2018; 7(2):130-133. PMC: 5982621. DOI: 10.5582/irdr.2018.01031. View

Saha S, Talukder S, Islam M, Saha S . A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J. 1999; 18(4):387. DOI: 10.1097/00006454-199904000-00018. View

Lunara Santos Pavelquesi S, Carolina Almeida de Oliveira Ferreira A, Rodrigues A, de Souza Silva C, Orsi D, Rodrigues da Silva I . Presence of Tetracycline and Sulfonamide Resistance Genes in spp.: Literature Review. Antibiotics (Basel). 2021; 10(11). PMC: 8615168. DOI: 10.3390/antibiotics10111314. View

Kaurthe J . Increasing antimicrobial resistance and narrowing therapeutics in typhoidal salmonellae. J Clin Diagn Res. 2013; 7(3):576-9. PMC: 3616589. DOI: 10.7860/JCDR/2013/4765.2831. View

Britto C, Wong V, Dougan G, Pollard A . A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS Negl Trop Dis. 2018; 12(10):e0006779. PMC: 6198998. DOI: 10.1371/journal.pntd.0006779. View

10.

Butler T, Rumans L, Arnold K . Response of typhoid fever caused by chloramphenicol-susceptible and chloramphenicol-resistant strains of Salmonella typhi to treatment with trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982; 4(2):551-61. DOI: 10.1093/clinids/4.2.551. View

11.

Cooles P . Adjuvant steroids and relapse of typhoid fever. J Trop Med Hyg. 1986; 89(5):229-31. View

12.

Umasankar S, Wall R, Berger J . A case of ciprofloxacin-resistant typhoid fever. Commun Dis Rep CDR Rev. 1992; 2(12):R139-40. View

13.

Chiou C, Lauderdale T, Phung D, Watanabe H, Kuo J, Wang P . Antimicrobial resistance in Salmonella enterica Serovar Typhi isolates from Bangladesh, Indonesia, Taiwan, and Vietnam. Antimicrob Agents Chemother. 2014; 58(11):6501-7. PMC: 4249406. DOI: 10.1128/AAC.03608-14. View

14.

Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A . The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb Drug Resist. 2003; 8(4):281-9. DOI: 10.1089/10766290260469543. View

15.

Singhal L, Gupta V, Gautam V, Kour I . XDR Warrants Vaccine Use in Asian Pacific Region: Prevention Is Still Better Than Cure. Asia Pac J Public Health. 2023; 35(6-7):463-464. DOI: 10.1177/10105395231199159. View

16.

Strahilevitz J, Jacoby G, Hooper D, Robicsek A . Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009; 22(4):664-89. PMC: 2772364. DOI: 10.1128/CMR.00016-09. View

17.

Hooper D, Jacoby G . Mechanisms of drug resistance: quinolone resistance. Ann N Y Acad Sci. 2015; 1354:12-31. PMC: 4626314. DOI: 10.1111/nyas.12830. View

18.

Gupta V, Pal K, Bhagat A, Goel A, Chander J . Quinolone Susceptibility in Isolates Based on Minimum Inhibitory Concentration Determination. J Lab Physicians. 2021; 12(4):263-267. PMC: 7773437. DOI: 10.1055/s-0040-1721163. View

19.

Veeraraghavan B, Anandan S, Muthuirulandi Sethuvel D, Ragupathi N . Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects. J Clin Diagn Res. 2016; 10(8):DL01-2. PMC: 5028453. DOI: 10.7860/JCDR/2016/17022.8306. View

20.

Parry C, Wijedoru L, Arjyal A, Baker S . The utility of diagnostic tests for enteric fever in endemic locations. Expert Rev Anti Infect Ther. 2011; 9(6):711-25. DOI: 10.1586/eri.11.47. View